Biomarkers of myocardial necrosis: past, present, and future / Robert H. Christenson and Hassan M.E. Azzazy -- Analytical issues for the clinical use of cardiac troponin / Alan H.B. Wu -- Defining myocardial infarction / Allan S. Jaffe and Luciano Babuin -- Biomarkers in the emergency department: rapid diagnosis and triage / Jin H. Han and W. Brian Gibler -- Cardiac troponin for risk assessment and management of non-ST-elevation acute coronary syndrome / Bertil Lindahl -- Biomarkers of necrosis for risk assessment and management of ST-elevation myocardial infarction / Evangelos Giannitsis and Hugo A. Katus -- Cardiac troponin after revascularization procedures / Warren J. Cantor and L. Kristin Newby -- Biomarkers of necrosis in heart failure: past, present, and future directions / Emil Missov, James Rider, and Leslie Miller -- Is there a role for cardiac troponin and other biomarkers in patients with pulmonary embolism? / Samuel Z. Goldhaber -- Cardiac troponin in conditions other than acute coronary syndromes / Fred S. Apple and David A. Morrow -- Degradation of cardiac troponins: implications for clinical practice / Allan S. Jaffe and Jennifer E. Van Eyk --

Developing a marker of ischemia: clinical and research challenges / Robert L. Jesse -- Emerging biomarkers of myocardial ischemia / Jesse E. Adams -- Inflammation in cardiovascular disease: the biological basis of inflammatory biomarkers / Peter Libby -- Analytic issues for the clinical use of C-reactive protein / Nader Rifai -- C-reactive protein as a tool for risk assessment in primary prevention / Shari S. Bassuk and Paul M. Ridker -- High-sensitivity C-reactive protein for risk assessment in acute coronary syndromes / Luigi M. Biasucci and Antonio Abbate -- Beyond C-reactive protein: novel markers of vascular inflammation / Christopher Heeschen -- Biomarkers of inflammation: implications in patients with heart failure / Biykem Bozkurt -- Biomarkers of infection and risk of coronary heart disease / Joseph B. Muhlestein -- Biology of the natriuretic peptides / Charlotte Kragelund and Torbjørn Omland -- Analytic issues for the clinical use of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide / Johannes Mair --

Clinical use of natriuretic peptides for the diagnosis and management of heart failure / Alan Maisel -- Natriuretic peptides in acute and chronic coronary artery disease / Shuaib M. Abdullah and James A. de Lemos -- Novel markers of hemodynamic stress / Ellen O. Weinberg and Richard T. Lee -- Clinical and research applications of markers of thrombosis / Manesh R. Patel and Richard C. Becker -- Measures of platelet activation and aggregation / Jean-Philippe Collet and Gilles Montalescot -- Monocyte-platelet aggregates in patients with ischemic heart disease / Matthew D. Linden and Mark I. Furman -- Measurement of atherogenic lipoproteins in cardiovascular risk assessment / Richard L. Dunbar and Daniel J. Rader -- Lipoprotein-associated phospholipase A₂ and other lipid-related biomarkers in cardiovascular disease / Natalie Khuseyinova and Wolfgang Koenig -- A multimarker approach to evaluation of patients with acute coronary syndrome / David A. Morrow -- Cardiac biomarkers by point-of-care testing / Paul O. Collinson -- Proteomics and cardiovascular biomarker discovery / Emerson Liu and Robert E. Gerszten -- Genetic markers in cardiovascular disease / Marc S. Sabatine.